Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Aymeric, Morlé"'
Autor:
Elisabetta Iessi, Luciana Zischler, Aurélie Etringer, Marion Bergeret, Aymeric Morlé, Guillaume Jacquemin, Alexandre Morizot, Sarah Shirley, Najoua Lalaoui, Selene L Elifio-Esposito, Stefano Fais, Carmen Garrido, Eric Solary, Olivier Micheau
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0126526 (2015)
Ezrin belongs to the ERM (ezrin-radixin-moesin) protein family and has been demonstrated to regulate early steps of Fas receptor signalling in lymphoid cells, but its contribution to TRAIL-induced cell death regulation in adherent cancer cells remain
Externí odkaz:
https://doaj.org/article/eef2c87f2c954a8994421d9e6467c3db
Autor:
Guillaume Jacquemin, Virginie Granci, Anne Sophie Gallouet, Najoua Lalaoui, Aymeric Morlé, Elisabetta Iessi, Alexandre Morizot, Carmen Garrido, Thierry Guillaudeux, Olivier Micheau
Publikováno v:
Haematologica, Vol 97, Iss 1 (2012)
Background Non-Hodgkin's B-cell lymphomas account for approximately 70% of B-cell lymphomas. While its incidence is dramatically increasing worldwide, the disease is still associated with high morbidity due to ineffectiveness of conventional therapie
Externí odkaz:
https://doaj.org/article/88d02b71c7d84aff84b141ff2dd2fc3d
Autor:
Najoua Lalaoui, Aymeric Morlé, Delphine Mérino, Guillaume Jacquemin, Elisabetta Iessi, Alexandre Morizot, Sarah Shirley, Bruno Robert, Eric Solary, Carmen Garrido, Olivier Micheau
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e19679 (2011)
TRAIL/Apo2L is a pro-apoptotic ligand of the TNF family that engages the apoptotic machinery through two pro-apoptotic receptors, TRAIL-R1 and TRAIL-R2. This cell death program is tightly controlled by two antagonistic receptors, TRAIL-R3 and TRAIL-R
Externí odkaz:
https://doaj.org/article/aa2a04798b2448c0ae89eea8de87a127
Autor:
Sebastien Causse, Renaud Seigneuric, Eva Szegezdi, Sarah Shirley, Guillaume Herlem, Aymeric Morlé, Tijani Gharbi, Florent Dufour, Andrei Constantinescu, Gilles Guichard, Al Batoul Zakaria, Olivier Micheau, Pascal Schneider, Gaelle Picarda, Thibault Rattier, Fabien Picaud, Guillaume Marcion, Dirk M. Zajonc, Carmen Garrido, Chris A. Benedict
Publikováno v:
Cell Death and Differentiation
Cell Death and Differentiation, Nature Publishing Group, 2017, [Epub ahead of print]. ⟨10.1038/cdd.2016.150⟩
Cell death and differentiation, vol. 24, no. 3, pp. 500-510
Cell Death and Differentiation, Nature Publishing Group, 2017, [Epub ahead of print]. ⟨10.1038/cdd.2016.150⟩
Cell death and differentiation, vol. 24, no. 3, pp. 500-510
International audience; APO2L/TRAIL (TNF-related apoptosis-inducing ligand) induces death of tumor cells through two agonist receptors, TRAIL-R1 and TRAIL-R2. We demonstrate here that N-linked glycosylation (N-glyc) plays also an important regulatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41691b65bb3cbadb464044124dae0bca
https://doi.org/10.1038/cdd.2016.150
https://doi.org/10.1038/cdd.2016.150
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1557
Analysis of CD95/Fas complexes by immunoprecipitation has long relied on the monoclonal antibody APO1 or tagged recombinant Fas ligand. Immunoprecipitation is an elegant and efficient procedure to investigate endogenous protein interactions or comple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d82efafbe9ef08e57baff1b970f7ff4
https://pubmed.ncbi.nlm.nih.gov/28247335
https://pubmed.ncbi.nlm.nih.gov/28247335
Publikováno v:
CD 95 : Methods and Protocols
Springer Protocols. CD 95 : Methods and Protocols, 1557, Humana Press, pp.19-31, 2017, 978-1493967780. ⟨10.1007/978-1-4939-6780-3_22⟩
Springer Protocols. CD 95 : Methods and Protocols, 1557, Humana Press, pp.19-31, 2017, 978-1493967780. ⟨10.1007/978-1-4939-6780-3_22⟩
Springer Protocols. CD 95 : Methods and Protocols, 1557, Humana Press, pp.19-31, 2017, 978-1493967780. 〈10.1007/978-1-4939-6780-3_22〉. 〈https://link.springer.com/protocol/10.1007%2F978-1-4939-6780-3_3〉
Methods in Molecular Biology ISBN: 9781493967780
Springer Protocols. CD 95 : Methods and Protocols, 1557, Humana Press, pp.19-31, 2017, 978-1493967780. ⟨10.1007/978-1-4939-6780-3_22⟩
Springer Protocols. CD 95 : Methods and Protocols, 1557, Humana Press, pp.19-31, 2017, 978-1493967780. ⟨10.1007/978-1-4939-6780-3_22⟩
Springer Protocols. CD 95 : Methods and Protocols, 1557, Humana Press, pp.19-31, 2017, 978-1493967780. 〈10.1007/978-1-4939-6780-3_22〉. 〈https://link.springer.com/protocol/10.1007%2F978-1-4939-6780-3_3〉
Methods in Molecular Biology ISBN: 9781493967780
Ce chapitre est compris dans un volume de la série Methods in Molecular Biology (ISSN 1064-3745); International audience; Analysis of CD95/Fas complexes by immunoprecipitation has long relied on the monoclonal antibody APO1 or tagged recombinant Fas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffdc3642cff479733079344ac1a01fe4
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01548294
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01548294
Autor:
Carmen Garrido, Pierre Vacher, Fabien Delacote, Patrick Legembre, Gilles Guichard, Hazem Ben Mabrouk, Thibault Rattier, Olivier Micheau, Florent Dufour, Guillaume Jacquemin, Etienne Humblin, Aymeric Morlé, Eva Szegezdi, Luciana Zischler, Naziha Marrakchi, Andrei Constantinescu, Catherine Pellat-Deceunynck
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2017, 8 (6), pp.9974-9985. 〈10.18632/oncotarget.14285〉
Oncotarget, Impact journals, 2017, 8 (6), pp.9974-9985. ⟨10.18632/oncotarget.14285⟩
Oncotarget, 2017, 8 (6), pp.9974-9985. ⟨10.18632/oncotarget.14285⟩
Oncotarget, Impact journals, 2017, 8 (6), pp.9974-9985. 〈10.18632/oncotarget.14285〉
Oncotarget, Impact journals, 2017, 8 (6), pp.9974-9985. ⟨10.18632/oncotarget.14285⟩
Oncotarget, 2017, 8 (6), pp.9974-9985. ⟨10.18632/oncotarget.14285⟩
// Florent Dufour 1, 2 , Thibault Rattier 1, 2 , Andrei Alexandru Constantinescu 1, 2 , Luciana Zischler 1, 2, 3 , Aymeric Morle 1, 2 , Hazem Ben Mabrouk 4 , Etienne Humblin 1, 2 , Guillaume Jacquemin 1, 2 , Eva Szegezdi 5 , Fabien Delacote 6 , Nazih
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875e92244d27b3002e2ce070bb204d09
http://www.hal.inserm.fr/inserm-01423110
http://www.hal.inserm.fr/inserm-01423110
Autor:
Julia D. Knopf, Lina Wunderle, Colin Adrain, Kvido Strisovsky, Nathalie Kühnle, Aymeric Morlé, Beate Hehn, Marius K. Lemberg, Matthew Freeman
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Scientific Reports
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Scientific Reports
Rhomboid intramembrane proteases are the enzymes that release active epidermal growth factor receptor (EGFR) ligands in Drosophila and C. elegans, but little is known about their functions in mammals. Here we show that the mammalian rhomboid protease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73bd076c6d7bbf78fc27c69476c527c0
Publikováno v:
2015, 〈10.1038/cddis.2015.12〉
2015, ⟨10.1038/cddis.2015.12⟩
2015, ⟨10.1038/cddis.2015.12⟩
TRAIL is involved in immune tumor surveillance and is considered a promising anti-cancer agent owing to its limited side effectson healthy cells. However, some cancer cells display resistance, or become resistant to TRAIL-induced cell death. Hyperthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::91cf4975ed157c5cebb4f632a2c5b0e7
http://www.hal.inserm.fr/inserm-01113424/document
http://www.hal.inserm.fr/inserm-01113424/document
Autor:
Anne Sophie Gallouet, Najoua Lalaoui, Guillaume Jacquemin, Thierry Guillaudeux, Elisabetta Iessi, Alexandre Morizot, Olivier Micheau, Aymeric Morlé, Carmen Garrido, Virginie Granci
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2012, 97 (1), pp.38-46. ⟨10.3324/haematol.2011.046466⟩
Haematologica, Ferrata Storti Foundation, 2012, 97 (1), pp.38-46. 〈10.3324/haematol.2011.046466〉
Haematologica, 2012, 97 (1), pp.38-46. ⟨10.3324/haematol.2011.046466⟩
Haematologica, Ferrata Storti Foundation, 2012, 97 (1), pp.38-46. ⟨10.3324/haematol.2011.046466⟩
Haematologica, Ferrata Storti Foundation, 2012, 97 (1), pp.38-46. 〈10.3324/haematol.2011.046466〉
Haematologica, 2012, 97 (1), pp.38-46. ⟨10.3324/haematol.2011.046466⟩
International audience; BACKGROUND: Non-Hodgkin's B-cell lymphomas account for approximately 70% of B-cell lymphomas. While its incidence is dramatically increasing worldwide, the disease is still associated with high morbidity due to ineffectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded4efc8d576ed43fdbd74643c6e9c91
https://www.hal.inserm.fr/inserm-00626580/file/Haematologica-Jacquemin-revised.pdf
https://www.hal.inserm.fr/inserm-00626580/file/Haematologica-Jacquemin-revised.pdf